POS0190 EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM TWO RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDIES
Eric F. Morand(Monash University), Y. Tanaka(University of Occupational and Environmental Health Japan), R. Furie(Northwell Health), Edward M Vital(University of Leeds), R. van Vollenhoven, Kenneth Kalunian, Marta Mosca(University of Pisa), Thomas Dörner(Charité - Universitätsmedizin Berlin), Daniel J. Wallace(Cedars-Sinai Medical Center), M. Silk(Eli Lilly (United States)), C. Dickson(Eli Lilly (United States)), Inmaculada de la Torre(Eli Lilly (United States)), G Mészáros(Eli Lilly (United States)), Bochao Jia(Eli Lilly (United States)), Byron Crowe(Eli Lilly (United States)), M. A. Petri(Johns Hopkins University)
Cited by 9Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis